Last reviewed · How we verify

Zero-dose

Sun Pharmaceutical Industries Limited · Phase 3 active Small molecule

Zero-dose is a vaccine candidate that uses a novel approach to stimulate an immune response without the need for a traditional vaccine dose.

Zero-dose is a vaccine candidate that uses a novel approach to stimulate an immune response without the need for a traditional vaccine dose. Used for COVID-19 prevention.

At a glance

Generic nameZero-dose
SponsorSun Pharmaceutical Industries Limited
ModalitySmall molecule
Therapeutic areaInfectious Diseases
PhasePhase 3

Mechanism of action

This is achieved through the use of a specific antigen and adjuvant combination that triggers a robust immune response, providing protection against the targeted disease. The exact mechanism of action is still being studied and refined.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: